Clinical trial EMBER-2
EMBER-2 : A phase 1, open-label, preoperative window study evaluating the biological effects of LY3484356 in post-menopausal women with stage I-III estrogen receptor-positive, HER2-negative breast cancer
| Cancers | |
|---|---|
| Organ | Breast |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1 |
| Academic trial | Non |
| Sponsor | Lilly |
| EudraCT Identifier | 2020-002810-42 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04647487 |
| Last update |